Proteomics-based Identification of VDAC1 As a Tumor Promoter in Cervical Carcinoma

Changlin Zhang,Wencheng Ding,Yuan Liu,Zheng Hu,Da Zhu,Xiaoli Wang,Lan Yu,Liming Wang,Hui Shen,Weican Zhang,Ci Ren,Kezhen Li,Danhui Weng,Wuguo Deng,Ding Ma,Hui Wang
DOI: https://doi.org/10.18632/oncotarget.10562
2016-01-01
Oncotarget
Abstract:We used oxidative isotope-coded affinity tags (OxICAT) to investigate the global redox status of proteins in human papillomavirus (HPV)-related cervical cancer cells, in order to identify a potential target for gene therapy. Voltage-dependent anion channel 1 (VDAC1) was found to be highly oxidized in HPV-positive cervical cancer cells. VDAC1 expression correlated significantly with the invasion of cervical cancer, the grade of cervical intraepithelial neoplasia (CIN) and the expression of HPV16 E7 in CIN. Knockdown of VDAC1 in cell lines increased the rate of apoptosis, while overexpression of the VDAC1 (respectively) partly reversed the effect. Thus, VDAC1 may promote the malignant progression of HPV-related disease, and treatments designed to suppress VDAC1 could prevent the progression of HPV-induced cervical disease.
What problem does this paper attempt to address?